At Medi-Radiopharma, our journey began as a family vision and grew into a global mission. For 30 years, we have been at the forefront of nuclear medicine—developing and delivering radiopharmaceuticals that support accurate diagnostics and life-saving therapies in more than 70 countries worldwide.
Driven by quality, rooted in trust, and inspired by innovation, we believe that no patient should miss a treatment due to lack of access.
From sterile lyophilized drug products to cutting-edge theragnostic solutions, we continuously invest in technology, talent, and infrastructure to meet the rising global demand.
We are proud of our people, our legacy, and our unwavering commitment to improving healthcare outcomes. Our long-term vision is simple: to grow with purpose, expand our capabilities, and ensure that nuclear medicine remains a pillar of modern healthcare.
Gergely Jánoki MSc. RPh, CEO.